7D8-28101-50377
4 vaccinations
2 coded responses
30 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 828 / WY
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Moderna
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-11
- 2021-01-18
- 2021-01-25
-
2021-01-26
Dose 2 — Moderna
-
2021-01-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-28
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-11
- 2021-04-27
- 2021-07-27
-
2021-10-29
Dose 3 — Moderna
-
2022-01-26
Survey response — 12 months, dose 2MedDRA: Cough, Rhinorrhoea — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-01-26
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-27
-
2022-10-04
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-15
- 2022-10-20
- 2022-10-27
- 2022-11-01
-
2023-01-03
Survey response — 3 months, dose 4MedDRA: Influenza — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-03
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-04
- 2023-01-04
-
2023-01-04
Call successfulNot applicable - Accidental Reporting
-
2023-01-04
Call successfulNot applicable - Accidental Reporting
- 2023-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-10-29 | Moderna | No |
| 4 | 2022-10-04 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-26 | Successful 2023-01-04 |
Not applicable - Accidental Reporting |
| 2023-01-03 | Successful 2023-01-04 |
Not applicable - Accidental Reporting |
Free text
Release 11 — 12 months, dose 2
Symptoms: Cough, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release